E 6 GLU 20 -12.381 -13.257
E 7 LEU 0 -10.391 -9.196
E 8 ARG 3 -12.322 -11.250
E 9 CYS 14 -15.032 -14.914
E 10 GLN 22 -14.194 -15.091
E 11 CYS 24 -14.923 -15.967
E 12 LEU 0 -14.363 -12.712
E 13 GLN 2 -12.562 -11.348
E 14 THR 22 -12.589 -13.671
E 15 LEU 17 -11.134 -11.809
E 16 GLN 1 -8.460 -7.602
E 17 GLY 14 -7.829 -8.538
E 18 ILE 25 -5.827 -8.032
E 19 HIS 6 -2.377 -2.793 <=B
E 20 PRO 14 -2.498 -3.820
E 21 LYS 0 -0.095 -0.084 <=B
E 22 ASN 14 -1.408 -2.856 <=B
E 23 ILE 26 -4.732 -7.178
E 24 GLN 9 -4.242 -4.789
E 25 SER 4 -7.199 -6.831
E 26 VAL 28 -9.842 -11.930
E 27 ILE 16 -11.202 -11.753
E 28 VAL 12 -11.706 -11.740
E 29 LYS 22 -12.166 -13.296
E 30 ALA 2 -12.365 -11.173
E 31 PRO 4 -11.814 -10.915
E 32 GLY 11 -10.723 -10.755
E 33 PRO 1 -8.159 -7.336
E 34 HIS 6 -10.169 -9.690
E 35 CYS 17 -13.288 -13.715
E 36 ALA 0 -11.777 -10.423
E 37 GLU 15 -13.054 -13.278
E 38 THR 11 -13.828 -13.503
E 39 GLU 21 -14.009 -14.813
E 40 VAL 21 -13.243 -14.135
E 41 ILE 16 -12.925 -13.278
E 42 ALA 30 -10.679 -12.901
E 43 THR 7 -8.566 -8.386
E 44 LEU 13 -5.514 -6.375
E 45 LYS 7 -1.561 -2.186 <=B
E 46 ASN 7 -2.008 -2.582 <=B
E 47 GLY 0 -4.572 -4.047
E 48 GLN 12 -6.694 -7.304
E 49 LYS 11 -10.032 -10.143
E 50 ALA 19 -11.639 -12.486
E 51 CYS 12 -13.610 -13.425
E 52 LEU 29 -12.368 -14.281
E 53 ASN 10 -11.378 -11.220
E 54 PRO 16 -11.149 -11.707
E 55 ALA 5 -9.470 -8.956
E 56 SER 21 -8.416 -9.863
E 57 PRO 0 -5.590 -4.947
E 58 MET 13 -4.547 -5.519
E 59 VAL 22 -7.919 -9.538
E 60 GLN 5 -6.749 -6.548
E 61 LYS 7 -2.674 -3.172 <=B
E 62 ILE 29 -3.676 -6.588
E 63 ILE 18 -6.291 -7.638
E 64 GLU 9 -2.685 -3.412 <=B
E 65 LYS 15 -1.110 -2.708 <=B
E 66 ILE 21 -2.796 -4.889
E 67 LEU 9 -2.078 -2.874 <=B
E 68 ASN 7 -0.640 -1.371 <=B
E 69 LYS 12 0.971 -0.521 <=B

Identified 11 B-Cell epitope residues out of 64 total residues